Article
The - 216G/T polymorphism in the EGFR gene: A review focusing on Non-Small lung cancer.
Molecular biology reports - 10 Dec 2025
Obradovic Jasmina, Jurisic Vladimir
Abstract excerpt
The epidermal growth factor receptor (EGFR) is a key regulator of cell proliferation and a well-established therapeutic target in non-small-cell lung cancer (NSCLC). Somatic mutations in the EGFR gene have been widely studied in the context of tyrosine kinase inhibitors (TKIs), but germline polymorphisms as potentially predictive biomarkers have emerged as a variants of interest over the years. Among these, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
